PL3402811T3 - Analogi egf(a) z podstawnikami kwasu tłuszczowego - Google Patents

Analogi egf(a) z podstawnikami kwasu tłuszczowego

Info

Publication number
PL3402811T3
PL3402811T3 PL17701078T PL17701078T PL3402811T3 PL 3402811 T3 PL3402811 T3 PL 3402811T3 PL 17701078 T PL17701078 T PL 17701078T PL 17701078 T PL17701078 T PL 17701078T PL 3402811 T3 PL3402811 T3 PL 3402811T3
Authority
PL
Poland
Prior art keywords
egf
analogues
fatty acid
acid substituents
substituents
Prior art date
Application number
PL17701078T
Other languages
English (en)
Inventor
Jianhe Chen
Jesper F. Lau
János Tibor Kodra
Birgit Wieczorek
Lars Linderoth
Henning THØGERSEN
Salka Elbøl RASMUSSEN
Patrick William Garibay
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of PL3402811T3 publication Critical patent/PL3402811T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/485Epidermal growth factor [EGF], i.e. urogastrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL17701078T 2016-01-13 2017-01-13 Analogi egf(a) z podstawnikami kwasu tłuszczowego PL3402811T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2016070791 2016-01-13
CN2016076580 2016-03-17
EP16195965 2016-10-27
EP17701078.2A EP3402811B1 (en) 2016-01-13 2017-01-13 Egf(a) analogues with fatty acid substituents
PCT/EP2017/050668 WO2017121850A1 (en) 2016-01-13 2017-01-13 Egf(a) analogues with fatty acid substituents

Publications (1)

Publication Number Publication Date
PL3402811T3 true PL3402811T3 (pl) 2022-07-11

Family

ID=57868232

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17701078T PL3402811T3 (pl) 2016-01-13 2017-01-13 Analogi egf(a) z podstawnikami kwasu tłuszczowego

Country Status (26)

Country Link
US (2) US10822385B2 (pl)
EP (1) EP3402811B1 (pl)
JP (2) JP6797926B2 (pl)
KR (1) KR102417487B1 (pl)
CN (1) CN108473550B (pl)
AU (1) AU2017207862B2 (pl)
BR (1) BR112018013820A2 (pl)
CA (1) CA3010756A1 (pl)
CL (1) CL2018001868A1 (pl)
CO (1) CO2018007440A2 (pl)
DK (1) DK3402811T3 (pl)
ES (1) ES2916998T3 (pl)
HR (1) HRP20220720T1 (pl)
HU (1) HUE058647T2 (pl)
IL (1) IL260043A (pl)
LT (1) LT3402811T (pl)
MX (1) MX2018008681A (pl)
MY (1) MY195199A (pl)
PE (1) PE20181376A1 (pl)
PH (1) PH12018501502A1 (pl)
PL (1) PL3402811T3 (pl)
RS (1) RS63298B1 (pl)
RU (1) RU2747877C2 (pl)
SA (1) SA518391996B1 (pl)
SI (1) SI3402811T1 (pl)
WO (1) WO2017121850A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170197947A1 (en) 2016-01-13 2017-07-13 Gruenenthal Gmbh 3-((Hetero-)Aryl)-Alkyl-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
US20170197949A1 (en) 2016-01-13 2017-07-13 Gruenenthal Gmbh 8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
LT3402811T (lt) 2016-01-13 2022-06-10 Novo Nordisk A/S Egf(a) analogai su riebalų rūgščių pakaitais
CN114149413A (zh) 2016-01-13 2022-03-08 格吕伦塔尔有限公司 3-((杂)芳基)-8-氨基-2-氧代-1,3-氮杂-螺-[4.5]-癸烷衍生物
MX378995B (es) 2016-01-13 2025-03-11 Gruenenthal Gmbh Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
CA3068956A1 (en) 2017-07-19 2019-01-24 Novo Nordisk A/S Bifunctional compounds
EP3655426A1 (en) * 2017-07-19 2020-05-27 Novo Nordisk A/S Egf(a) analogues, preparation, formulations and uses thereof
WO2019023295A1 (en) * 2017-07-27 2019-01-31 Saint Louis University Fatty acid modified human epidermal growth factor
KR102884527B1 (ko) 2018-06-21 2025-11-13 머크 샤프 앤드 돔 엘엘씨 Pcsk9 길항제 화합물
AR116605A1 (es) 2018-10-05 2021-05-26 Novo Nordisk As Compuestos bifuncionales que comprenden péptidos de insulina y péptidos de egf(a)
MX2021010767A (es) 2019-03-22 2021-09-28 3M Innovative Properties Company Sistema de proteccion contra caidas con sistema de monitoreo.
CN110357969B (zh) * 2019-05-27 2022-03-08 北京志道生物科技有限公司 一种GLP1-EGFa异源二聚体蛋白、功能及方法
CN114222581A (zh) 2019-08-07 2022-03-22 诺和诺德股份有限公司 包含egf(a)衍生物和n-(8-(2-羟基苯甲酰基)氨基)辛酸的盐的固体组合物
CA3154596A1 (en) 2019-11-07 2021-05-14 Simon Bjerregaard Solid compositions comprising a pcsk9 inhibitor and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
WO2021127460A1 (en) 2019-12-20 2021-06-24 Merck Sharp & Dohme Corp. Pcsk9 antagonist compounds
JP2024527488A (ja) 2021-07-02 2024-07-25 スリーエム イノベイティブ プロパティズ カンパニー 落下防止安全装置と連動される空中リフト
WO2023012263A1 (en) 2021-08-04 2023-02-09 Novo Nordisk A/S Solid oral peptide formulations

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1909823A2 (en) 2005-07-29 2008-04-16 Amprotein Corporation Chimeric therapeutic agents
CA2617649A1 (en) 2005-08-11 2007-02-22 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
ES2526924T3 (es) 2007-08-15 2015-01-16 Novo Nordisk A/S Insulinas con una fracción acilo que comprende unidades repetitivas de aminoácidos que contienen alquilenglicol
WO2009131740A2 (en) 2008-04-23 2009-10-29 Amgen Inc. Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof
WO2009143633A1 (en) 2008-05-30 2009-12-03 Institut De Recherches Cliniques De Montreal Pcsk9 inhibitors and methods of use thereof
TWI516501B (zh) 2008-09-12 2016-01-11 禮納特神經系統科學公司 Pcsk9拮抗劑類
CN101993485B (zh) 2009-08-20 2013-04-17 重庆富进生物医药有限公司 促胰岛素分泌肽类似物同源二聚体及其用途
CN103052900A (zh) 2010-08-02 2013-04-17 日本电气株式会社 偏振器和发光装置
CN102153652A (zh) 2010-12-10 2011-08-17 浙江大学 一种融合蛋白的表达方法及用途
EP2675470A1 (en) 2011-02-15 2013-12-25 Novo Nordisk A/S Long-acting il-1 receptor antagonists
MX2013015311A (es) * 2011-06-20 2014-03-31 Genentech Inc Polipeptidos de enlace de pcsk9 y metodos de uso.
JP6352806B2 (ja) * 2011-09-23 2018-07-04 ノヴォ ノルディスク アー/エス 新規のグルカゴン類似体
TW201315742A (zh) 2011-09-26 2013-04-16 Novartis Ag 治療代謝病症之雙功能蛋白質
CN104364262A (zh) * 2011-12-21 2015-02-18 诺沃—诺迪斯克有限公司 N末端修饰的胰岛素衍生物
US9745359B2 (en) 2012-05-18 2017-08-29 Adda Biotech Inc. Protein and protein conjugate for diabetes treatment, and applications thereof
AR092076A1 (es) 2012-08-22 2015-03-18 Lilly Co Eli Proteinas homodimericas
EP2892919A1 (en) 2012-09-07 2015-07-15 Sanofi Fusion proteins for treating a metabolic syndrome
CA2909581A1 (en) * 2013-04-18 2014-10-23 Novo Nordisk A/S Stable, protracted glp-1/glucagon receptor co-agonists for medical use
BR112016007255A2 (pt) 2013-10-03 2017-09-12 Moderna Therapeutics Inc polinucleotídeos que codificam receptor de lipoproteína de baixa densidade
BR112016017402A2 (pt) 2014-02-21 2017-10-17 Medimmune Ltd fusões anti-pcsk9~glp-1 e métodos para uso
US10570184B2 (en) * 2014-06-04 2020-02-25 Novo Nordisk A/S GLP-1/glucagon receptor co-agonists for medical use
CN104558198A (zh) 2014-07-25 2015-04-29 成都贝爱特生物科技有限公司 GLP-1类似物和amylin类似物的融合蛋白制备及其用途
EP3271379A4 (en) * 2015-03-19 2018-08-01 Institut de Cardiologie de Montréal Grp94 derived polypeptides for inhibiting pcsk9 and methods of use
CN105367884A (zh) 2015-11-02 2016-03-02 陈薇 一种绝缘耐火抗辐射的屏蔽电缆材料及其制备方法
LT3402811T (lt) 2016-01-13 2022-06-10 Novo Nordisk A/S Egf(a) analogai su riebalų rūgščių pakaitais
CA3068956A1 (en) 2017-07-19 2019-01-24 Novo Nordisk A/S Bifunctional compounds
EP3655426A1 (en) 2017-07-19 2020-05-27 Novo Nordisk A/S Egf(a) analogues, preparation, formulations and uses thereof

Also Published As

Publication number Publication date
US20190016768A1 (en) 2019-01-17
SI3402811T1 (sl) 2022-06-30
SA518391996B1 (ar) 2021-07-14
RS63298B1 (sr) 2022-07-29
US10822385B2 (en) 2020-11-03
MY195199A (en) 2023-01-11
AU2017207862B2 (en) 2020-12-17
KR102417487B1 (ko) 2022-07-06
MX2018008681A (es) 2018-09-17
ES2916998T3 (es) 2022-07-06
AU2017207862A1 (en) 2018-07-05
BR112018013820A2 (pt) 2018-12-11
US20200407409A1 (en) 2020-12-31
EP3402811B1 (en) 2022-03-30
CN108473550B (zh) 2022-11-22
IL260043A (en) 2018-07-31
LT3402811T (lt) 2022-06-10
PE20181376A1 (es) 2018-09-05
JP6797926B2 (ja) 2020-12-09
RU2747877C2 (ru) 2021-05-17
HRP20220720T1 (hr) 2022-09-30
JP2019505521A (ja) 2019-02-28
RU2018127882A3 (pl) 2020-06-19
RU2018127882A (ru) 2020-02-13
EP3402811A1 (en) 2018-11-21
PH12018501502A1 (en) 2019-03-25
HUE058647T2 (hu) 2022-09-28
CA3010756A1 (en) 2017-07-20
CN108473550A (zh) 2018-08-31
JP2021035989A (ja) 2021-03-04
CL2018001868A1 (es) 2018-08-31
WO2017121850A1 (en) 2017-07-20
DK3402811T3 (da) 2022-06-13
KR20180100177A (ko) 2018-09-07
CO2018007440A2 (es) 2018-09-28

Similar Documents

Publication Publication Date Title
IL260043A (en) egf(a) analogues with fatty acid converters
HUS2500009I1 (hu) PTH prodrugok
IL265588A (en) Treprostinil prodrugs
EP3090209A4 (en) A cooled grommet for a combustor wall assembly
GB201611674D0 (en) A turbine arrangement
GB2549510B (en) A Connector
LT3070231T (lt) Nuimama danga su užspaudžiama jungtimi
GB201419661D0 (en) Duct assembly with a connector
GB201420109D0 (en) A kite
ZA201607059B (en) Omega-3 analogues
GB201706271D0 (en) A connector
GB201417701D0 (en) A kite
PL3280879T3 (pl) Układ do turbiny
EP3102980A4 (en) High-power ultra-short pulse fiber laser-illuminated projector
GB201518909D0 (en) A formulation
PT3402811T (pt) Análogos de egf(a) com substituintes de ácidos gordos
HK1262866A1 (en) Egf(a) analogues with fatty acid substituents
LT3100836T (lt) Plokštės gamyba
AU201615213S (en) A head board
GB201507081D0 (en) Nozzle tip manufacturing
HK40027675A (en) Acrylic acid analogs
EP3658527A4 (en) ACRYLIC ACID ANALOGUES
GB2558331B (en) A banner
PH32015000107S1 (en) Tummy portion of a jeans (x-stitch)
PT3423103T (pt) Pró-fármacos de pth